If this is indeed the case and they have developed a method for reliably passing large peptide molecules through the skin, whoever is in charge of their business development plan ought to be dope-smacked...the market for such a system with legitimate pharmaceuticals is massive and to be wasting time and resources peddling "supplement" patches off a website is damned near criminal.
Somatropin is an FDA-approved pharmaceutical drug. It cannot, therefore, also be sold as a supplement. The FDA also considers any hormone-containing topical to be a drug, not a supplement.
This is from a violation letter from the FDA to another company offering a topical HGH product for sale...one that did not, ironically, even contain any HGH.
Moreover, under 21 CFR 310.530(b), any over-the-counter drug product that is labeled, represented, or promoted as a topically applied hormone-containing product for drug use, such as your firm's Derma-Tropin product, is regarded as a new drug within the meaning of section 201(P) of the Act (21 U.S.C. § 321(P)), and is misbranded under section 502 of the Act (21 U.S.C. § 352) unless an FDA-approved application is effect for it. Therefore, your sale of Derma-Tropin without an approved application renders it misbranded under section 502 of the Act, and the introduction or delivery for introduction into interstate commerce of this misbranded product violates section 301(a) of the Act (21 U.S.C. § 331(a))
Originally Posted by nanotechnology
Posting Permissions
Reply With Quote